EFM
KRTX

E Fund Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

E Fund Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,338
Closed -$740K – 384
2023
Q4 		$740K Sell
2,338
-144
-6% -$28K 0.05% 107
2023
Q3 		$420K Buy
2,482
+519
+26% +$97.6K 0.03% 161
2023
Q2 		$426K Sell
1,963
-194
-9% -$41.6K 0.03% 150
2023
Q1 		$392K Buy
2,157
+14
+0.7% +$2.68K 0.03% 173
2022
Q4 		$421K Buy
2,143
+229
+12% +$49.1K 0.04% 172
2022
Q3 		$431K Sell
1,914
-2,402
-56% -$486K 0.04% 163
2022
Q2 		$546K Buy
4,316
+1,709
+66% +$196K 0.05% 130
2022
Q1 		$331K Buy
+2,607
New +$294K 0.01% 173

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

E Fund Management's KRTX Position: Q1 2024 in Review

E Fund Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,338 shares — an estimated $740K sold.

E Fund Management first reported a position in KRTX in Q1 2022 and held it in 8 quarters. The position peaked at $740K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • E Fund Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • E Fund Management sold 2,338 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $740K.
  • E Fund Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • E Fund Management's Karuna Therapeutics, Inc. Common Stock position peaked at $740K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.